Key result
ICDs are linked to a ~3-fold higher depression prevalence vs PMs, with similar anxiety rates.
Why the study?
Anxiety and depression reduce quality of life in ICD recipients, but few studies have compared the frequency and severity of depressive and anxiety disorders between PM and ICD recipients.
Does the type of cardiac device (ICD vs PM) affect the prevalence of depression and anxiety in patients?
Cross-Sectional (n=296)
No
Does the type of cardiac device (ICD vs PM) affect the prevalence of depression and anxiety in patients?
Absolute Event Rate: 23% vs 7.1%
p-value: p=.03
ICD recipients experience a significantly higher prevalence of depression compared to pacemaker recipients, highlighting the need for targeted psychological screening and support in this population.
May support depression screening in ICD recipients; hypothesis-generating and requires prospective studies before practice change.
INTRODUCTION: Anxiety and depression among implantable cardioverter-defibrillator (ICD) recipients can lead to physical or psychological consequences and reduce the quality of life of these patients. Few studies have compared the frequency and severity of depressive and anxiety disorders in the pacemaker (PM) and ICD recipients. The aim of the present study was to compare depression and anxiety among PM and ICD recipients. METHODS: This cross-sectional study was performed on 296 patients referred to a specialized cardiology teaching hospital from October 1, 2019 to July 1, 2020. Patients were selected using convenience sampling method. RESULTS: Regarding anxiety, the results showed that the overall prevalence of anxiety in PM, ICD, and control groups was 23.5%, 28%, and 8%, respectively. Results showed no significant difference between PM and ICD recipients regarding the anxiety prevalence (p = .46). With regard to depression, the results showed that the overall prevalence of depression in the PM, ICD, and control groups was 7.1%, 23%, and 4.1%, respectively. The results showed a significant difference between PM and ICD recipients in terms of depression prevalence (p = .03). The results also showed that the prevalence of depression was significantly higher among PM and ICD recipients than the control group (p = .01). CONCLUSION: Considering the results of the present study and the high prevalence of anxiety and depression, it seems necessary to focus more on educating patients about the effectiveness of PM and ICD devices in reducing anxiety and depression.
No takes yet. Share an insight, caveat, or question.
Rafsanjani et al. (2020) conducted a cross-sectional in Pacemaker and implantable cardioverter-defibrillator recipients (n=296). Implantable cardioverter-defibrillator (ICD) vs. Pacemaker (PM) and control group was evaluated on Prevalence of depression (p=.03). Implantable cardioverter-defibrillator recipients had a significantly higher prevalence of depression compared to pacemaker recipients (23% vs 7.1%, p=0.03), while anxiety prevalence did not differ.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: